Lumida
/AROC
⌘K
Archrock Inc

Archrock Inc

AROC
$32.77USD+1.27%+0.41 today

MARKET CAP

5.7B

P/E (TTM)

17.8x

FWD P/E

DAY RANGE

$32 – $33

52W RANGE

$23
$42

AI Summary

Stalk
Buy NowMedium

In Stage 4, AROC is showing structural repair after an oversold decline, with price holding above the 9/20 EMAs and forming higher highs and lows. Short-term momentum is improving without exhaustion, and oversold conditions support a mean-reversion rally. A pullback into the EMA support zone offers a constructive entry for continuation. Failure to hold EMAs or break above key resistance would invalidate this recovery thesis.

  • Projects demand for +1 MM HP compression by 2030 supports organic growth.
  • Q2 contract ops revenue rose 3% YoY to $329 M with 94.4% HP utilization.
  • Q2 revenue down ~3% YoY to $371.2 M and EPS missed $0.45 est at $0.38.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Archrock, Inc. (NASDAQ: AROC) is a leading provider of natural gas compression services, which is critical for the transportation and processing of natural gas across the energy sector. Positioned favorably within the energy transition theme, Archrock operates primarily in the compression segment where it holds a robust market presence, with a focus on high horsepower equipment. The company has been leveraging its substantial resources to meet growing customer demands in the natural gas industry as companies seek to enhance their operational efficiencies amid rising energy needs.

Bull says

  • Projects demand for +1 MM HP compression by 2030 supports organic growth.
  • Q2 contract ops revenue rose 3% YoY to $329 M with 94.4% HP utilization.
  • Maintains 2.6× leverage and >$600 M liquidity with >70% contract margins.
  • Quarterly dividend increased to $0.23 (2.8% yield) underlines cash returns.
  • Strong momentum indicates potential upward stock trend amid energy recovery.
  • High growth and profitability metrics highlight operational efficiency and resilience.

Bear says

  • Q2 revenue down ~3% YoY to $371.2 M and EPS missed $0.45 est at $0.38.
  • GF Value™ implies ~27% overvaluation against intrinsic fair value.
  • High leverage (1.29×) and quality score concerns signal elevated financial risk.
  • Insider sales of $5.9 M over past quarter suggest limited management conviction.
  • Negative earnings yield and low book-to-price indicate valuation weakness.
  • Cost pressures and operational misses risk further performance setbacks.

Investment themes with AROC

High Dividend Yield -0.51%

Companies paying above-average dividends

AVGO · JPM · XOM

Earnings Call · Q1 2024 · Mgmt. Guidance

Updated 05-07-2025bullish

Transcript signals

Bull points

  • Net income for the first quarter of 2024 was $41 million. This included a noncash $3 million long-lived asset impairment. We reported adjusted EBITDA of $131 million for the first quarter 2024.
Read full transcript analysis ›